NCT00869011View on ClinicalTrials.gov

Exercise for Patients With Renal Cell Cancer Receiving Sunitinib

PHASE3UnknownINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2011

Conditions
Renal Cell Carcinoma
Interventions
OTHER

Endurance exercise

Endurance exercise, 3 times weekly for 35-45 minutes, 12 weeks.

Trial Locations (1)

12200

RECRUITING

Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, Berlin

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER